Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅱ

Clinical trial NCT04797013 · COMPLETED

Trial details

NCT number: NCT04797013
Sponsor: Beijing Tiantan Hospital
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2021-06-12
Primary completion: 2022-05-29
Enrollment: 1430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.